Morphochem and The Genetics Company announce the resolution of the X-ray structure of beta-secretase with a novel inhibitor
06-Jul-2005
Morphochem applied its protein expression, purification, crystallization and structure determination capabilities, all part of Morphochem's MOREsystem®, to generate biostructural information for further optimization of inhibitor compounds against beta-secretase identified by The Genetics Company as potential new therapeutic agents for Alzheimer's Disease.
Most read news
Topics
Organizations
morphochem
Genetics Company
Other news from the department science
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.